Topzle Topzle

Regeneron Pharmaceuticals

Updated: Wikipedia source

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

Infobox

Company type
Public
Traded as
mw- Nasdaq: REGNNasdaq-100 componentS&P 500 component
Industry
PharmaceuticalsBiotech
Founded
1988; 37 years ago (1988)
Founders
Leonard SchleiferGeorge Yancopoulos
Headquarters
Tarrytown, New York, U.S.
Area served
Global
Key people
Leonard Schleifer (CEO)George Yancopoulos (CSO)
Revenue
US$14.20 billion (2024)
Operating income
US$3.991 billion (2024)
Net income
US$4.413 billion (2024)
Total assets
US$37.76 billion (2024)
Total equity
US$29.35 billion (2024)
Number of employees
15,106 (2024)
Website
www.regeneron.com

Tables

· Financial performance
2012
2012
Financial year
2012
Revenue
$1.4 billion
2013
2013
Financial year
2013
Revenue
$2.1 billion
2014
2014
Financial year
2014
Revenue
$2.8 billion
2015
2015
Financial year
2015
Revenue
$4.1 billion
2016
2016
Financial year
2016
Revenue
$4.8 billion
2017
2017
Financial year
2017
Revenue
$5.8 billion
2018
2018
Financial year
2018
Revenue
$6.7 billion
2019
2019
Financial year
2019
Revenue
$7.8 billion
2020
2020
Financial year
2020
Revenue
$8.5 billion
2021
2021
Financial year
2021
Revenue
$16.1 billion
2022
2022
Financial year
2022
Revenue
$12.2 billion
2023
2023
Financial year
2023
Revenue
$13.1 billion
2024
2024
Financial year
2024
Revenue
$14.2 billion
Financial year
Revenue
2012
billion
2013
billion
2014
billion
2015
billion
2016
billion
2017
billion
2018
billion
2019
billion
2020
billion
2021
billion
2022
billion
2023
billion
2024
billion

References

  1. "Regeneron Pharmaceuticals, Inc. 2024 Annual Report (Form 10-K)"
    https://www.sec.gov/ix?doc=/Archives/edgar/data/872589/000180422025000011/regn-20241231.htm
  2. Forbes
    https://www.forbes.com/sites/matthewherper/2013/08/14/how-two-guys-from-queens-are-changing-drug-discovery/
  3. Forbes
    https://www.forbes.com/sites/forbesdigitalcovers/2018/07/26/regenerons-billionaire-founder-battles-the-drug-pricing-system/
  4. Bloomberg
    https://www.bloomberg.com/news/articles/2012-03-26/sanofi-regeneron-drug-lowers-cholesterol-up-to-72-in-study
  5. Genetic Engineering & Biotechnology News
    http://www.genengnews.com/gen-news-highlights/regeneron-sanofi-launch-2b-immuno-oncology-collaboration/81251558/
  6. FierceBiotech
    http://www.fiercebiotech.com/story/struggling-sanofi-paying-18b-partner-regeneron-immuno-oncology/2015-07-28
  7. Barron's
    https://www.barrons.com/articles/the-10-best-stocks-of-the-past-decade-51576628081
  8. The New York Times
    https://www.nytimes.com/2020/03/18/opinion/coronavirus-vaccine-cost.html
  9. BioPharma Dive
    https://www.biopharmadive.com/news/regeneron-hhs-coronavirus-antibody-development/571651/
  10. markets.ft.com
    https://markets.ft.com/data/announce/full?dockey=1330-8992408en-4SB6JLTDIDJHOAC14KRIJ3Q6L8
  11. Reuters
    https://www.reuters.com/article/us-sanofi-regeneron-idUKKBN2311TC
  12. Sanofi
    https://www.sanofi.com/en/media-room/press-releases/2020/2020-05-25-16-45-00-2038217
  13. "Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types"
    https://www.biospace.com/article/releases/regeneron-to-acquire-checkmate-pharmaceuticals-and-its-investigational-immune-activator-for-potential-use-in-multiple-tumor-types/?s=79
  14. "Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs"
    https://www.biospace.com/article/releases/regeneron-to-acquire-decibel-therapeutics-strengthening-gene-therapy-and-hearing-loss-programs/?s=79
  15. Regeneron Pharmaceuticals Purchases Avon in Suffern For $38.875 Million, To be Used For Research & Development Laborator
    https://rocklandreport.com/regeneron-pharmaceuticals-purchases-avon-in-suffern-for-38-875-million-to-be-used-for-research-development-laboratories/
  16. "Novartis, Ono Latest to Announce Billion-Dollar M&A Deals"
    https://www.biospace.com/article/biospace-mergers-and-acquisitions-tracker/?s=79
  17. FiercePharma
    https://www.fiercepharma.com/pharma/amgen-hook-pay-more-400m-after-regeneron-triumphs-cholesterol-drug-antitrust-suit
  18. HHS.gov
    https://web.archive.org/web/20210122035718/https://www.hhs.gov/about/news/2020/02/04/hhs-regeneron-collaborate-to-develop-2019-ncov-treatment.html
  19. Reuters
    https://web.archive.org/web/20200917055851/https://uk.reuters.com/article/uk-health-coronavirus-regeneron-antibody-idUKKBN2651TR
  20. BBC News
    https://www.bbc.com/news/health-54120753
  21. Regeneron Pharmaceuticals Inc
    https://www.regeneron.com/covid19
  22. HHS.gov
    https://web.archive.org/web/20201218071923/https://www.hhs.gov/about/news/2020/07/07/hhs-dod-collaborate-regeneron-large-scale-manufacturing-demonstration-project-covid-19-investigational-therapeutic-treatment.html
  23. Regeneron Pharmaceuticals Inc
    https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-manufacturing-and-supply-agreement-barda-and/
  24. YouTube
    https://www.youtube.com/watch?v=vYAtAASDO44&feature=emb_title
  25. Associated Press
    https://www.foxnews.com/politics/trump-coronavirus-treatment-walter-reed-regeneron-remsdesivir-dr-ronny-jackson
  26. "Analysis | The Health 202: Trump is taking Regeneron's new coronavirus treatment. It's used for mild symptoms"
    https://www.washingtonpost.com/politics/2020/10/05/health-202-trump-is-taking-regeneron-new-coronavirus-treatment-it-used-mild-symptoms/
  27. Twitter
    https://twitter.com/realdonaldtrump/status/1313959702104023047
  28. Regeneron Pharmaceuticals Inc
    https://web.archive.org/web/20201008185424/https://newsroom.regeneron.com/static-files/6feab76b-176d-402d-bf30-d40462e68b7b
  29. Morningstar.com
    https://web.archive.org/web/20210120071746/https://www.morningstar.com/articles/1017882/biopharma-companies-with-covid-19-treatments-see-10-billion-market-in-2021
  30. The New York Times
    https://www.nytimes.com/2011/11/19/business/regulators-approve-a-drug-for-an-eye-condition.html
  31. "FDA approves Zaltrap for metastatic colorectal cancer"
    https://web.archive.org/web/20130625115621/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm314372.htm
  32. "FDA approves Praluent to treat certain patients with high cholesterol"
    https://web.archive.org/web/20150727112659/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455883.htm
  33. CNBC
    https://www.cnbc.com/2018/05/01/regeneron-sanofi-chop-cholesterol-drug-price-in-express-scripts-pact.html
  34. "Regeneron and Sanofi Announce FDA Approval of Dupixent (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis"
    http://www.prnewswire.com/news-releases/regeneron-and-sanofi-announce-fda-approval-of-dupixent-dupilumab-the-first-targeted-biologic-therapy-for-adults-with-moderate-to-severe-atopic-dermatitis-300430441.html
  35. Regeneron Pharmaceuticals Inc.
    http://newsroom.regeneron.com/releasedetail.cfm?ReleaseID=1027419
  36. Regeneron Pharmaceuticals Inc
    https://www.regeneron.com/covid19
  37. clinicaltrials.gov
    https://clinicaltrials.gov/ct2/show/NCT04315298
  38. U.S. Food and Drug Administration (FDA)
    https://web.archive.org/web/20191215152539/https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-advanced-form-second-most-common-skin-cancer
  39. U.S. Food and Drug Administration (FDA)
    https://web.archive.org/web/20201015021206/https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-ebola-virus
  40. "Veopoz™ (pozelimab-bbfg) Receives FDA Approval as the First Treatment for Children and Adults with CHAPLE Disease | Regeneron Pharmaceuticals Inc"
    https://investor.regeneron.com/news-releases/news-release-details/veopoztm-pozelimab-bbfg-receives-fda-approval-first-treatment
  41. Susana Magadán Mompó and África González-Fernández. "Human Monoclonal Antibodies from Transgenic Mice". Chapter 13 in H
    http://www.nascentbiotech.com/wp-content/uploads/2014/09/Human_Monoclonal_Antibodies_2013_Whole_Book.pdf
  42. Stock Research
    https://www.macrotrends.net/stocks/charts/REGN/regeneron-pharmaceuticals/revenue
Image
Source: —
Tip: Wheel or +/− to zoom, drag to pan, Esc to close.